TY - JOUR
T1 - Host factors and cancer progression
T2 - Biobehavioral signaling pathways and interventions
AU - Lutgendorf, Susan K.
AU - Sood, Anil K.
AU - Antoni, Michael H.
PY - 2010/9/10
Y1 - 2010/9/10
N2 - Whereas evidence for the role of psychosocial factors in cancer initiation has been equivocal, support continues to grow for links between psychological factors such as stress, depression, and social isolation and progression of cancer. In vitro, in vivo, and clinical studies show that stress-related processes can impact pathways implicated in cancer progression, including immunoregulation, angiogenesis, and invasion. Contributions of systemic factors, such as stress hormones to the crosstalk between tumor and stromal cells, appear to be critical in modulating downstream signaling pathways with important implications for disease progression. Inflammatory pathways may also be implicated in fatigue and other factors related to quality of life. Although substantial evidence supports a positive effect of psychosocial interventions on quality of life in cancer, the clinical evidence for efficacy of stress-modulating psychosocial interventions in slowing cancer progression remains inconclusive, and the biobehavioral mechanisms that might explain such effects are still being established. This article reviews research findings to date and outlines future avenues of research in this area.
AB - Whereas evidence for the role of psychosocial factors in cancer initiation has been equivocal, support continues to grow for links between psychological factors such as stress, depression, and social isolation and progression of cancer. In vitro, in vivo, and clinical studies show that stress-related processes can impact pathways implicated in cancer progression, including immunoregulation, angiogenesis, and invasion. Contributions of systemic factors, such as stress hormones to the crosstalk between tumor and stromal cells, appear to be critical in modulating downstream signaling pathways with important implications for disease progression. Inflammatory pathways may also be implicated in fatigue and other factors related to quality of life. Although substantial evidence supports a positive effect of psychosocial interventions on quality of life in cancer, the clinical evidence for efficacy of stress-modulating psychosocial interventions in slowing cancer progression remains inconclusive, and the biobehavioral mechanisms that might explain such effects are still being established. This article reviews research findings to date and outlines future avenues of research in this area.
UR - http://www.scopus.com/inward/record.url?scp=77956922153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956922153&partnerID=8YFLogxK
U2 - 10.1200/JCO.2009.26.9357
DO - 10.1200/JCO.2009.26.9357
M3 - Review article
C2 - 20644093
AN - SCOPUS:77956922153
SN - 0732-183X
VL - 28
SP - 4094
EP - 4099
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 26
ER -